Immunome
IMNM
35 hedge funds and large institutions have $58.3M invested in Immunome in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 7 closing their positions.
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
72% more call options, than puts
Call options by funds: $2.12M | Put options by funds: $1.23M
42% more capital invested
Capital invested by funds: $41.1M → $58.3M (+$17.2M)
21% more funds holding
Funds holding: 29 → 35 (+6)
0.13% more ownership
Funds ownership: 20.21% → 20.34% (+0.13%)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.62M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.23M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.03M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$320K |
| 5 |
HT
HAP Trading
New York
|
+$313K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.95M |
| 2 |
RI
Ridgewood Investments
Springfield,
New Jersey
|
-$523K |
| 3 |
Two Sigma Investments
New York
|
-$511K |
| 4 |
Renaissance Technologies
New York
|
-$353K |
| 5 |
Millennium Management
New York
|
-$272K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EMG
26
ETF Managers Group
Summit,
New Jersey
| $101K | +$12.7K | +729 | +21% |
|
|
LC
27
Lindbrook Capital
Calabasas,
California
| $24K | +$17.4K | +1,000 | New |
|
|
CG
28
Cutler Group
San Francisco,
California
| $17K | +$12.5K | +719 | New |
|
29
US Bancorp
Minneapolis,
Minnesota
| $3K | +$1.95K | +112 | New |
|
30
Osaic Holdings
Scottsdale,
Arizona
| $2K | -$3.49K | -200 | -67% |
|
|
31
Fidelity Investments
Boston,
Massachusetts
| $1K | -$3.95M | -226,424 | -100% |
|
32
Simplex Trading
Chicago,
Illinois
| $1K | – | – | – |
|
33
Wells Fargo
San Francisco,
California
| $1K | +$523 | +30 | +103% |
|
|
34
Two Sigma Investments
New York
| – | -$511K | -29,516 | Closed |
|
|
35
Renaissance Technologies
New York
| – | -$353K | -20,400 | Closed |
|
|
ECM
36
ExodusPoint Capital Management
New York
| – | -$221K | -12,800 | Closed |
|
|
E
37
Ergoteles
New York
| – | -$173K | -10,006 | Closed |
|
38
UBS Group
Zurich,
Switzerland
| – | -$23.7K | -1,356 | -99% |
|
39
JP Morgan Chase
New York
| – | -$13K | -768 | Closed |
|
|
TRCT
40
Tower Research Capital (TRC)
New York
| – | -$2K | -100 | Closed |
|
IMNM Hedge Fund Activity: Q3 2021 in Review
35 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q3 2021, worth a combined $58.3M — up 42% from $41.1M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new IMNM positions and 7 closed out — a net gain of 6 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $1.62M. The largest seller was Fidelity Investments, cutting an estimated $3.95M.
- 35 institutional investors held Immunome (IMNM) as of Q3 2021, up from 29 in Q2 2021.
- Funds reported $58.3M of Immunome stock for Q3 2021, up 42% quarter-over-quarter.
- 13 funds opened new Immunome positions in Q3 2021 and 7 closed out, a net change of +6 holders.
- The largest Immunome buyer in Q3 2021 was Bank of Montreal, an estimated $1.62M added.
- The largest Immunome seller in Q3 2021 was Fidelity Investments, an estimated $3.95M sold.
Based on aggregated 13F filings for Q3 2021.